These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30261551)

  • 1. Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.
    Caccuri F; Muraro E; Gloghini A; Turriziani O; Riminucci M; Giagulli C; Mastorci K; Fae' DA; Fiorentini S; Caruso A; Carbone A; Dolcetti R
    Hematol Oncol; 2019 Apr; 37(2):176-184. PubMed ID: 30261551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Dolcetti R; Giagulli C; He W; Selleri M; Caccuri F; Eyzaguirre LM; Mazzuca P; Corbellini S; Campilongo F; Marsico S; Giombini E; Muraro E; Rozera G; De Paoli P; Carbone A; Capobianchi MR; Ippolito G; Fiorentini S; Blattner WA; Lu W; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14331-6. PubMed ID: 26578780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.
    Carroll VA; Lafferty MK; Marchionni L; Bryant JL; Gallo RC; Garzino-Demo A
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13168-13173. PubMed ID: 27799525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lymphomagenic role for HIV beyond immune suppression?
    Dolcetti R; Gloghini A; Caruso A; Carbone A
    Blood; 2016 Mar; 127(11):1403-9. PubMed ID: 26773045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms Involved in the B Cell Growth and Clonogenic Activity of HIV-1 Matrix Protein p17 Variants.
    D'Ursi P; Rondina A; Zani A; Uggeri M; Messali S; Caruso A; Caccuri F
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma.
    Selleri M; Dolcetti R; Caccuri F; Giombini E; Rozera G; Abbate I; Mammone A; Zanussi S; Martorelli D; Fiorentini S; Caruso A; Capobianchi MR
    New Microbiol; 2017 Jan; 40(1):58-61. PubMed ID: 28072889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.
    Li S; Bozzo L; Wu Z; Lu W; Romerio F
    New Microbiol; 2010 Jan; 33(1):13-24. PubMed ID: 20402410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
    He W; Mazzuca P; Yuan W; Varney K; Bugatti A; Cagnotto A; Giagulli C; Rusnati M; Marsico S; Diomede L; Salmona M; Caruso A; Lu W; Caccuri F
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):13-24. PubMed ID: 30248376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.
    Giagulli C; D'Ursi P; He W; Zorzan S; Caccuri F; Varney K; Orro A; Marsico S; Otjacques B; Laudanna C; Milanesi L; Dolcetti R; Fiorentini S; Lu W; Caruso A
    Sci Rep; 2017 Jul; 7(1):6555. PubMed ID: 28747658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding to PI(4,5)P
    Bugatti A; Caccuri F; Filippini F; Ravelli C; Caruso A
    J Biol Chem; 2021 Aug; 297(2):100934. PubMed ID: 34273353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.
    Mazzuca P; Marsico S; Schulze K; Mitola S; Pils MC; Giagulli C; Guzman CA; Caruso A; Caccuri F
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation.
    Giagulli C; Caccuri F; Zorzan S; Bugatti A; Zani A; Filippini F; Manocha E; D'Ursi P; Orro A; Dolcetti R; Caruso A
    Cancer Gene Ther; 2021 Jun; 28(6):649-666. PubMed ID: 33093643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
    Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
    J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis.
    Cagliuso M; Conti V; Trasarti S; Lombardi L; Riminucci M; Perez M; Turriziani O; Falasca F; Nanni M; Tafuri A; Mezzaroma I
    Infection; 2013 Feb; 41(1):255-8. PubMed ID: 23007326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide.
    Caccuri F; Messali S; Zani A; Campisi G; Giovanetti M; Zanussi S; Vaccher E; Fabris S; Bugatti A; Focà E; Castelli F; Ciccozzi M; Dolcetti R; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2122050119. PubMed ID: 35763571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
    de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
    Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.
    Basta D; Latinovic O; Lafferty MK; Sun L; Bryant J; Lu W; Caccuri F; Caruso A; Gallo R; Garzino-Demo A
    Pathog Dis; 2015 Nov; 73(8):ftv062. PubMed ID: 26333571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.